SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-039425
Filing Date
2023-06-23
Accepted
2023-06-23 16:40:23
Documents
2
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1600
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 7109
  Complete submission text file 0001209191-23-039425.txt   10036
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Issuer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address
Thorpe Catherine (Reporting) CIK: 0001982109 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38898 | Film No.: 231038316